Latest News in the Business and Financial World

Friday, April 16, 2021
Log in
  • Home
  • Company News & Financials
  • OTC Markets
  • Tech & Science
  • Health & LifeStyle
  • About WS OTC
    • Analysts & Contributors
    • Contact Us
    • Advertising
    • Feedback
    • Privacy Policy GDPR
  • Mobile
  • Latest News
    • New Theories Explain the Disappearance of the Mayan Civilization
    • What Happens If Coral Reefs Die?
    • Monsanto Loses Lawsuit for its Herbicide Products
    • Mankind (MNKD) shares Plunge after FDA Approves Afrezza, inhaled Insulin for Diabetes patients
    • Psychologists Confirm that Violent Video Games Boost Aggressiveness
    • World of Warcraft: Warlords of Draenor Release Date on Nov 13
    • iPass Global Hotspot Map Unveils Worldwide Wi-fi Coverage

Pages

  • About Wall Street OTC
  • Advertising
  • Analysts & Contributors
  • Contact
  • Feedback
  • Mobile
  • Privacy Policy GDPR
  • Terms of Service

Recent Posts

  • SF Hospital Slaps New Parents with $19K Bill for Baby Treatment
  • Furious Trump Blasts Harley-Davidson for Moving Production Overseas
  • Warning! MRI Machines Could Poison You
  • Flight Attendants More Likely to Get Certain Cancers
  • More Red Meat Allergy Cases Related to Lone Star Tick Bites

FDA Approves Gilead’s Lymphoma (Blood cancer) drug idelalisib (Zydelig)

Jul 23, 2014 By Richard Carlisle Leave a Comment

Email, RSS Follow

The Food and Drug Administration (FDA) has given green signal to Gilead Sciences for its drug idelalisib (Zydelig) for treating three types of relapse lymphoma, one of the forms of blood cancer.

While announcing the decision, Richard Pazdur of FDA said that Zydelig (idelalisib) is the third drug which has been approved with an advance designation for treating CLL patients. Moreover, this is the fifth drug overall to receive this breakthrough designation.

Earlier, obinutuzumab (Gazyva) received FDA clearance for CLL in November 2013. Another drug ibrutinib (Imbruvica) got FDA approval in February this year followed by ofatumumab (Arzerra) in April.

The drug will now treat chronic lymphocytic leukemia (CLL) in relapsed setting along with rituximab (Rituxan). The other two lymphomas for which the federal agency has given a go ahead to Gilead Sciences are relapsed small lymphocytic lymphoma (SLL) and relapsed follicular B-cell non-Hodgkin lymphoma.

antibiotics broken market

150 mg tablets of Zydelig (idelalisib) will treat the patients suffering from the three mentioned B-cell blood cancers as it is a first-in-class inhibitor of the delta isoform of phosphoinositide 3-kinase (PI3K delta), a protein found in B-cell malignancies which influence the proliferation and migration of cancerous cells.

Pazdur, director of the Office of Hematology and Oncology Products, said in a statement, “In less than a year, we have seen considerable progress in the availability of treatments for chronic lymphocytic leukemia.”

“Zydelig’s approval to treat CLL reflects the promise of the breakthrough therapy designation program and represents the FDA’s commitment to working cooperatively with companies to expedite a drug’s development, review, and approval,” the statement further said.

It is noteworthy, the federal agency has cautioned against several fatal risks linked to idelalisib including disease like severe diarrhea, colitis, hepatotoxicity, intestinal perforation and pneumonitis.

Gilead (NASDAQ:GILD) Sciences stock prices has moved by 1.13 percent and are trading at $90.34 at the moment.

Email, RSS Follow
The following two tabs change content below.
  • Bio
  • Latest Posts

Richard Carlisle

Richard is a product of the 90s and a serious fan of the Star Wars series. He graduated from the University of Florida with a degree in Applied Physiology and Kinesiology; therefore, he has a great understanding of the relationship between physical activity and mental health. Although he has a full- time job in a clinic, he enjoys covering news related to health and the United States.

Latest posts by Richard Carlisle (see all)

  • Yes, Science Made Low-Fat Bacon Possible (Study) - Oct 31, 2017
  • Scientists Report Success In Experimental Therapy To Prevent Zika - Oct 5, 2017
  • A Paper-Based Test Can Seemingly Detect Zika In A Matter Of Minutes - Sep 29, 2017

Filed Under: Health & LifeStyle Tagged With: Blood Cancer, FDA, Food and Drug Administration, Gilead’s cancer drug, idelalisib (Zydelig), Lymphoma, Zydelig

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 72 other subscribers

Mom holding newborn's hands

SF Hospital Slaps New Parents with $19K Bill for Baby Treatment

Jun 29, 2018 By Anne-Marie Jackson Leave a Comment

Harley-Davidson biker

Furious Trump Blasts Harley-Davidson for Moving Production Overseas

Jun 28, 2018 By Anne-Marie Jackson Leave a Comment

MRI machine

Warning! MRI Machines Could Poison You

Jun 27, 2018 By Anne-Marie Jackson Leave a Comment

Flight Attendants More Likely to Get Certain Cancers

Jun 27, 2018 By Anne-Marie Jackson Leave a Comment

Lone star tick sitting on a succulent leaf

More Red Meat Allergy Cases Related to Lone Star Tick Bites

Jun 26, 2018 By Anne-Marie Jackson Leave a Comment

Time magazine cover

Time Admits Sobbing Cover Girl Was Not Separated from Parents

Jun 26, 2018 By Anne-Marie Jackson Leave a Comment

Sunshine and green leaves

Vitamin D Deficiency Could Boost Risk of Lung Disease

Jun 25, 2018 By Anne-Marie Jackson Leave a Comment

Green-light laser pointer

Greek Boy’s Retina Severely Damaged by Laser Pointer

Jun 22, 2018 By Anne-Marie Jackson Leave a Comment

Red Tesla car

Tesla Suing ‘Whistleblower’ over Data Theft

Jun 21, 2018 By Anne-Marie Jackson Leave a Comment

Boiled eggs and mayonnaise

Eating too Clean Can Lead to Orthorexia

Jun 20, 2018 By Anne-Marie Jackson Leave a Comment

NYC mayor Bill de Blasio

NYC Will Allow People to Smoke Pot in Public

Jun 20, 2018 By Anne-Marie Jackson Leave a Comment

A kitten and a puppy sleeping in a bed while hugging each other

Who Is Smarter Between Cats and Dogs? Researchers Have an Answer (Study)

Jun 19, 2018 By Anne-Marie Jackson Leave a Comment

Orthodox church in Greece

Being Religious Is Tied to Longer Lifespan, Study

Jun 19, 2018 By Anne-Marie Jackson Leave a Comment

Bacon and eggs for breakfast

How Does the Keto Diet Work?

Jun 18, 2018 By Anne-Marie Jackson Leave a Comment

Related Articles

  • Mom holding newborn's hands

    SF Hospital Slaps New Parents with $19K Bill for Baby Treatment

    Jun 29, 2018
  • MRI machine

    Warning! MRI Machines Could Poison You

    Jun 27, 2018
  • Lone star tick sitting on a succulent leaf

    More Red Meat Allergy Cases Related to Lone Star Tick Bites

    Jun 26, 2018
  • Sunshine and green leaves

    Vitamin D Deficiency Could Boost Risk of Lung Disease

    Jun 25, 2018
  • Green-light laser pointer

    Greek Boy’s Retina Severely Damaged by Laser Pointer

    Jun 22, 2018
  • Boiled eggs and mayonnaise

    Eating too Clean Can Lead to Orthorexia

    Jun 20, 2018
  • Orthodox church in Greece

    Being Religious Is Tied to Longer Lifespan, Study

    Jun 19, 2018
  • Office workers

    Free Workplace Food Is Packed with Empty Calories (Study)

    Jun 13, 2018
  • Basil leaves in a wooden spoon next to some cherry tomatoes

    Plant Foods Are the Secret to Longevity and a Healthy Life

    Jun 12, 2018
  • hotel room

    Scientists Paying Volunteers $3,500 to Stay at ‘Flu Hotel’

    Jun 11, 2018

Categories

  • Business
  • Company News & Financials
  • Diversified Financial
  • Entertainment
  • Featured
  • Health & LifeStyle
  • Micro Cap
  • Mid Cap
  • National News
  • Nature
  • OTC Exchange
  • OTC Markets
  • OTC Research
  • Science
  • Small Cap
  • Sports
  • Tech & Science
  • U.S.
  • Uncategorized
  • Wall Street
  • World
  • World Indexes

Copyright © 2021 wallstreetotc.com

About · Privacy Policy · Sitemap · Terms of Service · Contact